Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Variability in phenotype induced by the podocin variant R229Q plus a single pathogenic mutation.

Phelan PJ, Hall G, Wigfall D, Foreman J, Nagaraj S, Malone AF, Winn MP, Howell DN, Gbadegesin R.

Clin Kidney J. 2015 Oct;8(5):538-42. doi: 10.1093/ckj/sfv063. Epub 2015 Jul 20.

2.

Gq signaling causes glomerular injury by activating TRPC6.

Wang L, Jirka G, Rosenberg PB, Buckley AF, Gomez JA, Fields TA, Winn MP, Spurney RF.

J Clin Invest. 2015 May;125(5):1913-26. doi: 10.1172/JCI76767. Epub 2015 Apr 6.

3.

HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome.

Gbadegesin RA, Adeyemo A, Webb NJ, Greenbaum LA, Abeyagunawardena A, Thalgahagoda S, Kale A, Gipson D, Srivastava T, Lin JJ, Chand D, Hunley TE, Brophy PD, Bagga A, Sinha A, Rheault MN, Ghali J, Nicholls K, Abraham E, Janjua HS, Omoloja A, Barletta GM, Cai Y, Milford DD, O'Brien C, Awan A, Belostotsky V, Smoyer WE, Homstad A, Hall G, Wu G, Nagaraj S, Wigfall D, Foreman J, Winn MP; Mid-West Pediatric Nephrology Consortium.

J Am Soc Nephrol. 2015 Jul;26(7):1701-10. doi: 10.1681/ASN.2014030247. Epub 2014 Oct 27.

4.

Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis.

Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS, Jiang R, Lindsey TB, Wu G, Sparks MA, Smith SR, Webb NJ, Kalra PA, Adeyemo AA, Shaw AS, Conlon PJ, Jennette JC, Howell DN, Winn MP, Gbadegesin RA.

Kidney Int. 2014 Dec;86(6):1253-9. doi: 10.1038/ki.2014.305. Epub 2014 Sep 17.

5.

A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGS.

Hall G, Gbadegesin RA, Lavin P, Wu G, Liu Y, Oh EC, Wang L, Spurney RF, Eckel J, Lindsey T, Homstad A, Malone AF, Phelan PJ, Shaw A, Howell DN, Conlon PJ, Katsanis N, Winn MP.

J Am Soc Nephrol. 2015 Apr;26(4):831-43. doi: 10.1681/ASN.2013101053. Epub 2014 Aug 21.

6.

Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.

Hall G, Rowell J, Farinelli F, Gbadegesin RA, Lavin P, Wu G, Homstad A, Malone A, Lindsey T, Jiang R, Spurney R, Tomaselli GF, Kass DA, Winn MP.

Am J Physiol Renal Physiol. 2014 Jun 15;306(12):F1442-50. doi: 10.1152/ajprenal.00212.2013. Epub 2014 Apr 16.

7.

Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS.

Gbadegesin RA, Hall G, Adeyemo A, Hanke N, Tossidou I, Burchette J, Wu G, Homstad A, Sparks MA, Gomez J, Jiang R, Alonso A, Lavin P, Conlon P, Korstanje R, Stander MC, Shamsan G, Barua M, Spurney R, Singhal PC, Kopp JB, Haller H, Howell D, Pollak MR, Shaw AS, Schiffer M, Winn MP.

J Am Soc Nephrol. 2014 Sep;25(9):1991-2002. doi: 10.1681/ASN.2013090976. Epub 2014 Mar 27.

8.

TNXB mutations can cause vesicoureteral reflux.

Gbadegesin RA, Brophy PD, Adeyemo A, Hall G, Gupta IR, Hains D, Bartkowiak B, Rabinovich CE, Chandrasekharappa S, Homstad A, Westreich K, Wu G, Liu Y, Holanda D, Clarke J, Lavin P, Selim A, Miller S, Wiener JS, Ross SS, Foreman J, Rotimi C, Winn MP.

J Am Soc Nephrol. 2013 Jul;24(8):1313-22. doi: 10.1681/ASN.2012121148. Epub 2013 Apr 25.

9.

Genetic testing in nephrotic syndrome--challenges and opportunities.

Gbadegesin RA, Winn MP, Smoyer WE.

Nat Rev Nephrol. 2013 Mar;9(3):179-84. doi: 10.1038/nrneph.2012.286. Epub 2013 Jan 15. Review.

10.

A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.

Malik TH, Lavin PJ, Goicoechea de Jorge E, Vernon KA, Rose KL, Patel MP, de Leeuw M, Neary JJ, Conlon PJ, Winn MP, Pickering MC.

J Am Soc Nephrol. 2012 Jul;23(7):1155-60. doi: 10.1681/ASN.2012020166. Epub 2012 May 24.

11.

Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis.

Akilesh S, Suleiman H, Yu H, Stander MC, Lavin P, Gbadegesin R, Antignac C, Pollak M, Kopp JB, Winn MP, Shaw AS.

J Clin Invest. 2011 Oct;121(10):4127-37. doi: 10.1172/JCI46458. Epub 2011 Sep 12.

12.

Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis.

Gbadegesin RA, Lavin PJ, Hall G, Bartkowiak B, Homstad A, Jiang R, Wu G, Byrd A, Lynn K, Wolfish N, Ottati C, Stevens P, Howell D, Conlon P, Winn MP.

Kidney Int. 2012 Jan;81(1):94-9. doi: 10.1038/ki.2011.297. Epub 2011 Aug 24.

13.

TORCing up the importance of calcium signaling.

Lavin PJ, Winn MP.

J Am Soc Nephrol. 2011 Aug;22(8):1391-3. doi: 10.1681/ASN.2011060595. Epub 2011 Jul 14. No abstract available.

14.

Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector.

Luo X, Hall G, Li S, Bird A, Lavin PJ, Winn MP, Kemper AR, Brown TT, Koeberl DD.

Mol Ther. 2011 Nov;19(11):1961-70. doi: 10.1038/mt.2011.126. Epub 2011 Jul 5.

15.

Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation.

Jungraithmayr TC, Hofer K, Cochat P, Chernin G, Cortina G, Fargue S, Grimm P, Knueppel T, Kowarsch A, Neuhaus T, Pagel P, Pfeiffer KP, Schäfer F, Schönermarck U, Seeman T, Toenshoff B, Weber S, Winn MP, Zschocke J, Zimmerhackl LB.

J Am Soc Nephrol. 2011 Mar;22(3):579-85. doi: 10.1681/ASN.2010010029. Epub 2011 Feb 25.

16.

TRPC6 enhances angiotensin II-induced albuminuria.

Eckel J, Lavin PJ, Finch EA, Mukerji N, Burch J, Gbadegesin R, Wu G, Bowling B, Byrd A, Hall G, Sparks M, Zhang ZS, Homstad A, Barisoni L, Birbaumer L, Rosenberg P, Winn MP.

J Am Soc Nephrol. 2011 Mar;22(3):526-35. doi: 10.1681/ASN.2010050522. Epub 2011 Jan 21.

17.

Modulation of the BP response to diet by genes in the renin-angiotensin system and the adrenergic nervous system.

Svetkey LP, Harris EL, Martin E, Vollmer WM, Meltesen GT, Ricchiuti V, Williams G, Appel LJ, Bray GA, Moore TJ, Winn MP, Conlin PR.

Am J Hypertens. 2011 Feb;24(2):209-17. doi: 10.1038/ajh.2010.223. Epub 2010 Nov 18.

18.

A new locus for familial FSGS on chromosome 2p.

Gbadegesin R, Lavin P, Janssens L, Bartkowiak B, Homstad A, Wu G, Bowling B, Eckel J, Potocky C, Abbott D, Conlon P, Scott WK, Howell D, Hauser E, Winn MP.

J Am Soc Nephrol. 2010 Aug;21(8):1390-7. doi: 10.1681/ASN.2009101046. Epub 2010 Jul 8.

19.

Exclusion of homozygous PLCE1 (NPHS3) mutations in 69 families with idiopathic and hereditary FSGS.

Gbadegesin R, Bartkowiak B, Lavin PJ, Mukerji N, Wu G, Bowling B, Eckel J, Damodaran T, Winn MP.

Pediatr Nephrol. 2009 Feb;24(2):281-5. doi: 10.1007/s00467-008-1025-5. Epub 2008 Oct 31.

20.

Therapeutic targets in focal and segmental glomerulosclerosis.

Lavin PJ, Gbadegesin R, Damodaran TV, Winn MP.

Curr Opin Nephrol Hypertens. 2008 Jul;17(4):386-92. doi: 10.1097/MNH.0b013e32830464f4. Review.

21.

2007 Young Investigator Award: TRP'ing into a new era for glomerular disease.

Winn MP.

J Am Soc Nephrol. 2008 Jun;19(6):1071-5. doi: 10.1681/ASN.2007121292. Epub 2008 Apr 23.

22.

TRPC6 and FSGS: the latest TRP channelopathy.

Mukerji N, Damodaran TV, Winn MP.

Biochim Biophys Acta. 2007 Aug;1772(8):859-68. Epub 2007 Mar 20. Review.

23.

Focal and segmental glomerulosclerosis.

Daskalakis N, Winn MP.

Cell Mol Life Sci. 2006 Nov;63(21):2506-11. Review.

PMID:
16952054
24.
25.

Unexpected role of TRPC6 channel in familial nephrotic syndrome: does it have clinical implications?

Winn MP, Daskalakis N, Spurney RF, Middleton JP.

J Am Soc Nephrol. 2006 Feb;17(2):378-87. Epub 2006 Jan 5. Review. No abstract available.

26.

A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis.

Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB.

Science. 2005 Jun 17;308(5729):1801-4. Epub 2005 May 5.

27.

Symptoms of gastro-oesophageal reflux disease and the severity of obstructive sleep apnoea syndrome are not related in sleep disorders center patients.

Kim HN, Vorona RD, Winn MP, Doviak M, Johnson DA, Ware JC.

Aliment Pharmacol Ther. 2005 May 1;21(9):1127-33.

28.

Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery.

Stafford-Smith M, Podgoreanu M, Swaminathan M, Phillips-Bute B, Mathew JP, Hauser EH, Winn MP, Milano C, Nielsen DM, Smith M, Morris R, Newman MF, Schwinn DA; Perioperative Genetics and Safety Outcomes Study (PEGASUS) Investigative Team.

Am J Kidney Dis. 2005 Mar;45(3):519-30.

PMID:
15754274
29.

Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index.

Vorona RD, Winn MP, Babineau TW, Eng BP, Feldman HR, Ware JC.

Arch Intern Med. 2005 Jan 10;165(1):25-30.

PMID:
15642870
30.

Approach to the evaluation of heritable diseases and update on familial focal segmental glomerulosclerosis.

Winn MP.

Nephrol Dial Transplant. 2003 Aug;18 Suppl 6:vi14-20. Review.

PMID:
12953036
31.

Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.

Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Ondo WG, Allen FH Jr, Scott BL, Goetz CG, Small GW, Mastaglia F, Stajich JM, Zhang F, Booze MW, Winn MP, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM.

Ann Neurol. 2003 May;53(5):624-9.

PMID:
12730996
32.

Linkage of a gene causing familial membranoproliferative glomerulonephritis type III to chromosome 1.

Neary JJ, Conlon PJ, Croke D, Dorman A, Keogan M, Zhang FY, Vance JM, Pericak-Vance MA, Scott WK, Winn MP.

J Am Soc Nephrol. 2002 Aug;13(8):2052-7.

33.

Not all in the family: mutations of podocin in sporadic steroid-resistant nephrotic syndrome.

Winn MP.

J Am Soc Nephrol. 2002 Feb;13(2):577-9. Review. No abstract available.

34.

Evidence for genetic factors in the development and progression of IgA nephropathy.

Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF.

Kidney Int. 2000 May;57(5):1818-35. Review.

35.

Spectrum of disease in familial focal and segmental glomerulosclerosis.

Conlon PJ, Lynn K, Winn MP, Quarles LD, Bembe ML, Pericak-Vance M, Speer M, Howell DN.

Kidney Int. 1999 Nov;56(5):1863-71.

36.

Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity.

Winn MP, Conlon PJ, Lynn KL, Howell DN, Slotterbeck BD, Smith AH, Graham FL, Bembe M, Quarles LD, Pericak-Vance MA, Vance JM.

Genomics. 1999 Jun 1;58(2):113-20.

PMID:
10368108
37.

Acute renal failure following cardiac surgery.

Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K.

Nephrol Dial Transplant. 1999 May;14(5):1158-62.

PMID:
10344355
38.

Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation.

Winn MP, Alkhunaizi AM, Bennett WM, Garber RL, Howell DN, Butterly DW, Conlon PJ.

Am J Kidney Dis. 1999 May;33(5):970-4.

PMID:
10213658
39.

Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. International Collaborative Group for the Study of Familial Focal Segmental Glomerulosclerosis.

Winn MP, Conlon PJ, Lynn KL, Howell DN, Gross DA, Rogala AR, Smith AH, Graham FL, Bembe M, Quarles LD, Pericak-Vance MA, Vance JM.

Kidney Int. 1999 Apr;55(4):1241-6.

40.

Dialysis catheter 'fibrin-sheath stripping': a cautionary tale!

Winn MP, McDermott VG, Schwab SJ, Conlon PJ.

Nephrol Dial Transplant. 1997 May;12(5):1048-50. No abstract available.

PMID:
9175070
41.

Orthostatic acute renal failure in a renal transplant.

Winn MP, Bollinger RR, Conlon PJ.

Transpl Int. 1997;10(5):395-7.

PMID:
9287407

Supplemental Content

Support Center